Adverse effects of OKT3 therapy: increased risk with impaired renal function.
Kehinde
E O
EO
Department of Surgery, Leicester General Hospital, United Kingdom.
Scriven
S D
SD
Feehally
J
J
Veitch
P S
PS
Varty
K
K
Bell
P R
PR
D000328:Adult; D002102:Cadaver; D004351:Drug Resistance; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects*; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use; D014019:Tissue Donors
D016853:Muromonab-CD3; D013256:Steroids